Duloxetine and pregnancy outcomes: safety surveillance findings

Duloxetine hydrochloride is approved for the treatment or management of major depressive disorder, generalized anxiety disorder, diabetic peripheral neuropathic pain, chronic musculoskeletal pain, and fibromyalgia in the United States. These conditions affect millions of women, including those of ch...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of medical sciences 2013-01, Vol.10 (4), p.413-419
Hauptverfasser:	Hoog, Sharon L, Cheng, Yingkai, Elpers, John, Dowsett, Sherie A
Format:	Artikel
Sprache:	eng
Schlagworte:	Abortion, Spontaneous - chemically induced Adult Adverse Drug Reaction Reporting Systems Antidepressive Agents - administration & dosage Antidepressive Agents - adverse effects Depressive Disorder, Major - drug therapy Drug-Related Side Effects and Adverse Reactions - epidemiology Drug-Related Side Effects and Adverse Reactions - pathology Duloxetine Hydrochloride Female Humans Infant Infant, Newborn Pregnancy Pregnancy Complications - chemically induced Pregnancy Outcome - epidemiology Research Paper Thiophenes - administration & dosage Thiophenes - adverse effects United States United States Food and Drug Administration
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!